Eli Lilly and WuXi AppTec contributed to what was reportedly a down round for T-cell oncology treatment developer Immunocore following a $320m raise in 2015.

Eli Lilly and WuXi AppTec contributed to what was reportedly a down round for T-cell oncology treatment developer Immunocore following a $320m raise in 2015.

University of Tokyo Edge Capital has returned to invest in AI-assisted cardiac diagnosis technology developer Tricog Health.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The immuno-oncology therapy developer has raised a sliver over $100m, Takeda Ventures leading a round that included M Ventures, Ipsen Ventures and MRL Ventures Fund.

The university has put together a $1m fund for health-oriented participants in its Velocity accelerator competition.

The Comcast, McKesson, Humana and Independence Health-backed digital health concierge developer has set an initial target of $100m for its proposed flotation.

Anthem and existing investor Comcast Ventures took part in a round that reportedly boosted medical advice app developer K Health's overall funding to about $97m.

Wego has provided $34m for Neurovasc in connection with a joint development agreement and clinical trials covering neurovascular disease treatments.

BlueCross BlueShield Venture Partners co-led a series C round for AxialHealthcare, developer of a medication-addiction mitigation platform.